method-of-treatment
3 cases — ← All topics
| Case | Title | Lower Court | Docketed | Status | Flags | Tags | Question Presented |
|---|---|---|---|---|---|---|---|
| 20-1604 | Biogen MA Inc. v. EMD Serono, Inc., et al. | Federal Circuit | 2021-05-18 | Denied | anticipation claim-construction incentives medical-treatment method-of-treatment novelty patent patent-law patent-validity prior-art recombinant-protein | Whether courts may disregard the express claim term "recombinant" so as to render a method-of-treatment patent anticipated—and thus invalid—in light o… | |
| 19-1103 | INO Therapeutics LLC, et al. v. Praxair Distribution Inc., et al. | Federal Circuit | 2020-03-10 | Denied | Response Waived | 35-usc-101 drug-administration due-process eligibility innovation medical-research medical-treatment method-of-treatment patent patent-eligibility patient-outcomes personalized-medicine section-101 selective-treatment | Whether a method of treatment that requires doctors to selectively administer a drug to certain patients and not others to enhance patient outcomes is… |
| 18-817 | Hikma Pharmaceuticals USA Inc., et al. v. Vanda Pharmaceuticals Inc. | Federal Circuit | 2018-12-27 | Denied | CVSGAmici (3)Relisted (2) | generic-drugs inventive-concept medical-patent medical-treatment method-of-treatment natural-law patent-eligibility routine-and-conventional section-101 | Whether patents that claim a method of medically treating a patient automatically satisfy Section 101 of the Patent Act, even if they apply a natural … |